DJIA 17,689.86 -56.12 -0.32%
NASDAQ 5,128.28 -0.50 -0.01%
S&P 500 2,103.84 -4.79 -0.23%
market minute promo

Vertex Pharmaceuticals (NASDAQ: VRTX)

135.00 -0.46 (-0.34%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRTX $135.00 -0.34%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $134.89
Previous Close $135.46
Daily Range $133.02 - $136.00
52-Week Range $84.41 - $137.50
Market Cap $32.9B
P/E Ratio -45.61
Dividend (Yield) $0.00 (0.0%)
Volume 1,545,537
Average Daily Volume 1,762,262
Current FY EPS -$2.00

Sector

Healthcare

Industry

Drug Makers

Vertex Pharmaceuticals (VRTX) Description

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. Website: http://www.vrtx.com/

News & Commentary Rss Feed

Vertex Pharmaceuticals Rolls Along

Solid quarter, but Orkambi sales in future quarters will dictate the biotech’s fate.

Vertex Posts Wider Y/Y Loss but Raises Kalydeco Outlook - Analyst Blog

3 Drugs Stocks Pushing Industry Growth

Vertex Pharmaceuticals (VRTX) Earnings Report: Q2 2015 Conference Call Transcript

Vertex Pharmaceuticals (VRTX) Jeffrey M. Leiden on Q2 2015 Results - Earnings Call Transcript

Trade-Ideas: Vertex Pharmaceuticals (VRTX) Is Today's Post-Market Leader Stock

Biotech Stock Roundup: Biogen Down on Tecfidera Issues, Regeneron's Praluent Gets FDA Nod - Analyst

Biotech Stock Roundup: Biogen Down on Tecfidera Issues, Regeneron's Praluent Gets FDA Nod - Analyst Blog

Earnings Reaction History: Vertex Pharmaceuticals Incorporated, 66.7% Follow-Through Indicator, 3.8%

Earnings Reaction History: Vertex Pharmaceuticals Incorporated, 66.7% Follow-Through Indicator, 3.8% Sensitive

The Secret to Vertex Pharmaceuticals' Success

Originally set out to treat the hepatitis C market, Vertex has successfully pivoted its focus to the cystic fibrosis market instead, where it looks poised for strong growth.

Will Vertex (VRTX) Surprise with a Lower Loss in Q2? - Analyst Blog

See More VRTX News...

VRTX's Top Competitors

VRTX $135.00 (-0.34%)
Current stock: VRTX
AMGN $176.59 (2.85%)
Current stock: AMGN
GILD $117.86 (-0.03%)
Current stock: GILD
BIIB $318.78 (0.56%)
Current stock: BIIB